Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)
24.12
+0.02 (0.08%)
Mar 10, 2026, 3:33 PM HKT
HKG:6826 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | - | 420.45 | 416.12 | 180.47 | 352.23 | Upgrade
|
| Depreciation & Amortization | - | 203.86 | 197.86 | 200.89 | 159.95 | Upgrade
|
| Other Amortization | - | 1.37 | - | 3.33 | 2.89 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0.02 | -0.59 | 0.51 | 0.37 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 46.07 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -25.92 | -2.3 | 7.78 | -0.02 | Upgrade
|
| Loss (Gain) on Equity Investments | - | -0.99 | -0.46 | -3.51 | -2.19 | Upgrade
|
| Stock-Based Compensation | - | 3 | 14.3 | 30.23 | - | Upgrade
|
| Provision & Write-off of Bad Debts | - | -2.23 | -1.97 | 15.52 | -3.18 | Upgrade
|
| Other Operating Activities | - | -93.7 | -61.7 | -66.5 | -191.69 | Upgrade
|
| Change in Accounts Receivable | - | -39.35 | 10.13 | -52.33 | -41.92 | Upgrade
|
| Change in Inventory | - | 5.32 | -48.42 | -138.86 | -28.63 | Upgrade
|
| Change in Accounts Payable | - | 62.62 | 43.48 | 35.44 | 32.35 | Upgrade
|
| Change in Other Net Operating Assets | - | 114.12 | 67.99 | -27.75 | 62.13 | Upgrade
|
| Operating Cash Flow | - | 648.57 | 634.45 | 231.3 | 342.29 | Upgrade
|
| Operating Cash Flow Growth | - | 2.23% | 174.30% | -32.43% | 30.61% | Upgrade
|
| Capital Expenditures | - | -364.18 | -265.6 | -309.21 | -270.88 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.72 | 1.84 | 0.39 | 0.21 | Upgrade
|
| Cash Acquisitions | - | -17.58 | - | -2.94 | -83.28 | Upgrade
|
| Divestitures | - | - | - | 17.59 | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | -1.31 | -1.63 | -7.94 | -1.22 | Upgrade
|
| Investment in Securities | - | 586.14 | -189.68 | -468.55 | 52.67 | Upgrade
|
| Other Investing Activities | - | 75.98 | 78.42 | 88.84 | 154.4 | Upgrade
|
| Investing Cash Flow | - | 282.28 | -376.65 | -681.82 | -148.09 | Upgrade
|
| Long-Term Debt Issued | - | 242 | 313.89 | 65.94 | 38.01 | Upgrade
|
| Long-Term Debt Repaid | - | -221.08 | -40.93 | -69.7 | -119.5 | Upgrade
|
| Net Debt Issued (Repaid) | - | 20.92 | 272.96 | -3.76 | -81.49 | Upgrade
|
| Issuance of Common Stock | - | 49.45 | 73.68 | - | - | Upgrade
|
| Repurchase of Common Stock | - | -175.35 | -269.98 | -147.67 | -44.91 | Upgrade
|
| Common Dividends Paid | - | -259.86 | -68.52 | -121.89 | -87.91 | Upgrade
|
| Other Financing Activities | - | -25.51 | -265.87 | -15.03 | -16.94 | Upgrade
|
| Financing Cash Flow | - | -390.35 | -257.73 | -288.35 | -231.25 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 3.08 | 10.05 | 14.17 | -6.94 | Upgrade
|
| Net Cash Flow | - | 543.59 | 10.12 | -724.7 | -43.99 | Upgrade
|
| Free Cash Flow | - | 284.39 | 368.85 | -77.91 | 71.41 | Upgrade
|
| Free Cash Flow Growth | - | -22.90% | - | - | -1.34% | Upgrade
|
| Free Cash Flow Margin | - | 10.61% | 14.00% | -3.70% | 4.08% | Upgrade
|
| Free Cash Flow Per Share | - | 1.22 | 1.55 | -0.23 | 0.21 | Upgrade
|
| Cash Interest Paid | - | 18.06 | 5.1 | 4.99 | 3 | Upgrade
|
| Cash Income Tax Paid | - | 115.59 | 88.19 | 43.72 | 70.22 | Upgrade
|
| Levered Free Cash Flow | - | 206.16 | 209.26 | -112.91 | -9.78 | Upgrade
|
| Unlevered Free Cash Flow | - | 217.44 | 213.82 | -108.16 | -6.68 | Upgrade
|
| Change in Working Capital | - | 142.71 | 73.19 | -183.49 | 23.93 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.